Poor Merck and their plan to fight all the Vioxx cases one at a time.
Currently they have won one and lost one.
Now Carol Higbee, the New Jersey judge overseeing about 3,500 Vioxx cases in Mercks' heartland has "upped the ante", told lawyers in a private conference on Monday that she wants the next 10 or so trials in her courtroom to involve plaintiffs who took the drug for 18 months or longer.
That's going to make defence much harder. Merck themselves acknowledged last year that Vioxx increased heart-attack risks when people used it daily for 18 months or more, and it pulled the drug from the market based on that conclusion.
Source: WSJ
No comments:
Post a Comment